Tilray Brands, Inc.

TLRY

US88688T1007

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-05 pm EDT			5-day change	1st Jan Change
1.73 ^USD	0.00%		+4.22%	-24.78%

Jun. 27	Tilray Brands Launches Non-Alcoholic Brand Runner's High Brewing	MT
Jun. 27	Tilray Brands, Inc. Announces Runner's High Brewing Company - Its New Brand of Premium Non-Alcoholic Brews	CI

Tilray Brands, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2023

January 09, 2024 at 07:00 am EST

Tilray Brands, Inc. reported earnings results for the second quarter and six months ended November 30, 2023. For the second quarter, the company reported sales was USD 193.77 million compared to USD 144.14 million a year ago. Net loss was USD 46.18 million compared to USD 61.64 million a year ago. Basic loss per share from continuing operations was USD 0.07 compared to USD 0.11 a year ago.
For the six months, sales was USD 370.72 million compared to USD 297.35 million a year ago. Net loss was USD 102.05 million compared to USD 127.43 million a year ago. Basic loss per share from continuing operations was USD 0.17 compared to USD 0.24 a year ago.

Latest news about Tilray Brands, Inc.

Tilray Brands Launches Non-Alcoholic Brand Runner's High Brewing	Jun. 27	MT
Tilray Brands, Inc. Announces Runner's High Brewing Company - Its New Brand of Premium Non-Alcoholic Brews	Jun. 27	CI
Breckenridge Distillery Releases Award-Winning Collectors Art Series Collaboration with Abby Wren	Jun. 25	CI
Tilray Medical Introduces Broken Coast Medical Cannabis Brand in Australia	Jun. 20	MT
Tilray Brief: Tilray Medical Launching Broken Coast Medical Cannabis Brand in Australia	Jun. 20	MT
Tilray Brands, Inc. Announces the Launch of 'Purple Churro,' by Redecan Cannabis	Jun. 06	CI
Tilray Brands, Inc. Announces Good Supply Launches 'Twisted' All-In-One Vape	May. 30	CI
Solei Brand Introduces New Cannabis-Infused ?Warming Deep Tissue Stick?	May. 23	CI
TSX rises on commodity strength, CPI data in focus next week	May. 17	RE
Toronto Stocks Edge Higher; Tilray Brands Shares Fall on $250 Million Share Sale Plans	May. 17	DJ
Tilray Brands Plans Up To $250 Million 'At-The-Market' Offering -- Shares Fall	May. 17	MT
Tilray Brands Launches At-The-Market Share Sale to Fund Acquisitions and Investments	May. 17	MT
Tilray Brief: Announcing At-The-Market Program to Fund Strategic and Accretive Acquisitions and Accelerate Expansion Plan Upon U.S. Cannabis Rescheduling When Effective	May. 17	MT
Social Buzz: Wallstreetbets Stocks Advance Premarket Friday; Reddit, AMC Entertainment to Open Higher	May. 17	MT
Cannabis stocks rally after DOJ proposal to reclassify marijuana	May. 16	RE
Pot stocks rise as US unveils proposal to ease restrictions on marijuana	May. 16	RE
US Government Reclassifies Marijuana to Less-Restrictive Category	May. 16	MT
Canopy Growth, Tilray Shares Rise After DOJ Proposes Marijuana Reclassification	May. 16	DJ
Justice Department Set to Post Cannabis Reclassification Plans	May. 16	MT
Stocks Uneven Pre-Bell as Wall Street Awaits Producer Price Report; Asia, Europe Churn	May. 14	MT
Investors wary of US cannabis ETFs despite recent rally	May. 07	RE
Tilray Brands, Inc Launches XMG Zero, a New ?Better for You? Cannabis Beverage	May. 02	CI
Tilray Brands, Inc.'s Subsidiary Widmer Brothers Brewing Launches New Hefe Variety Pack With Revamped Versions of the Original American Hefeweizen	May. 01	CI
Health Care Flat Amid Mixed Earnings -- Health Care Roundup	Apr. 30	DJ
TSX loses monthly winning streak as US rate cut prospects ebb	Apr. 30	RE

Chart Tilray Brands, Inc.

Duration

Period

More charts

Company Profile

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis business, Distribution business, Beverage alcohol business and Wellness business. The Cannabis business segment is engaged in the production, distribution, sale, co-manufacturing, and advisory services of both medical and adult-use cannabis. The Distribution business segment is focused on the purchase and resale of pharmaceutical products to customers. The Beverage alcohol business segment is engaged in the production, marketing and sale of beverage and beverage alcohol products. The Wellness business segment includes hemp foods and hemp-based cannabidiol (CBD) consumer products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Bake Sale, XMG, Mollo, and others.

Sector

Pharmaceuticals

Calendar

2024-07-23 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

US Consumer Confused About Pot Rules, Tilray CEO Says

October 17, 2023 at 02:38 pm EDT

More Strategies

Ratings for Tilray Brands, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

1.73 USD

Average target price

2.398 USD

Spread / Average Target

+38.62%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
TILRAY BRANDS, INC.	-24.78%	1.43B
ELI LILLY AND COMPANY	+56.89%	823B
NOVO NORDISK A/S	+39.52%	627B
JOHNSON & JOHNSON	-6.55%	353B
MERCK & CO., INC.	+15.99%	320B
ABBVIE INC.	+7.92%	295B
ASTRAZENECA PLC	+13.74%	239B
NOVARTIS AG	+13.83%	220B
ROCHE HOLDING AG	-0.49%	219B
AMGEN INC.	+7.94%	167B

Other Pharmaceuticals